Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Solaro
Gianluigi Mancardi

Showing results (1-10 of 226) with videos related to

Pageof 23
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 18, 2008
Symptomatic therapies in multiple sclerosis. IntroductionClaudio Solaro, Gianluigi Mancardi
Neurology(R) Neuroimmunology & Neuroinflammation|October 31, 2017
Teriflunomide treatment reduces B cells in patients with MSIlaria Gandoglia, Federico Ivaldi, Alice Laroni, et al.
The Lancet. Neurology|February 3, 2009
Further data on autologous haemopoietic stem cell transplantation in multiple sclerosisGianluigi Mancardi
Multiple Sclerosis and Related Disorders|April 7, 2019
CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MSMatteo Pardini, Lorenzo Gualco, Giulia Bommarito, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 14, 2016
Autologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experienceDaniela Currò, Gianluigi Mancardi
Current Opinion in Neurology|April 9, 2010
Stem cell transplantation in multiple sclerosisAntonio Uccelli, Gianluigi Mancardi
The Lancet. Neurology|June 21, 2008
Autologous haematopoietic stem-cell transplantation in multiple sclerosisGianluigi Mancardi, Riccardo Saccardi
Neurology|March 15, 2006
Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofenClaudio Solaro
The New England Journal of Medicine|June 4, 2002
High-dose intravenous immune globulin for stiff-person syndromeClaudio Solaro
European Journal of Neurology|July 6, 2011
Evaluate symptomatic therapy in MS: can clinical trials be fine-tuned?Claudio Solaro
Pageof 23

Showing results (1-10 of 226) with videos related to

Sort By:
Pageof 23
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 18, 2008
Symptomatic therapies in multiple sclerosis. IntroductionClaudio Solaro, Gianluigi Mancardi
Neurology(R) Neuroimmunology & Neuroinflammation|October 31, 2017
Teriflunomide treatment reduces B cells in patients with MSIlaria Gandoglia, Federico Ivaldi, Alice Laroni, et al.
The Lancet. Neurology|February 3, 2009
Further data on autologous haemopoietic stem cell transplantation in multiple sclerosisGianluigi Mancardi
Multiple Sclerosis and Related Disorders|April 7, 2019
CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MSMatteo Pardini, Lorenzo Gualco, Giulia Bommarito, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 14, 2016
Autologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experienceDaniela Currò, Gianluigi Mancardi
Current Opinion in Neurology|April 9, 2010
Stem cell transplantation in multiple sclerosisAntonio Uccelli, Gianluigi Mancardi
The Lancet. Neurology|June 21, 2008
Autologous haematopoietic stem-cell transplantation in multiple sclerosisGianluigi Mancardi, Riccardo Saccardi
Neurology|March 15, 2006
Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofenClaudio Solaro
The New England Journal of Medicine|June 4, 2002
High-dose intravenous immune globulin for stiff-person syndromeClaudio Solaro
European Journal of Neurology|July 6, 2011
Evaluate symptomatic therapy in MS: can clinical trials be fine-tuned?Claudio Solaro
Pageof 23